Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews · Infectious Diseases

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 4 · 100%

Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in antigenaemia prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 1.07 [0.91, 1.25]
2 studies · 1054 participants
High

Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in antigenaemia prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 1.03 [0.92, 1.14]
5 studies · 954 participants
High

Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in antigenaemia prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 1.04 [0.94, 1.16]
2 studies · 1766 participants
High

Antigenaemia prevalence · people with lymphatic filariasis or communities where lymphatic filariasis is endemic

The intervention showed no clear difference in antigenaemia prevalence (high certainty).

1 finding from 1 review

Albendazole alone or in combination with microfilaricidal drugs for lymphatic filariasis 2019 · Cochrane Headline outcomes only
RR 1.04 [0.97, 1.12]
7 studies · 3774 participants
High